H.R. 7837: Most Favored Patient Act of 2026
Sponsor
Daniel Meuser
Republican · PA-9
HR7837 Legislative Journey
House: Committee Action
Mar 5, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
About the Sponsor
Daniel Meuser
Republican, Pennsylvania's 9th congressional district · 7 years in Congress
Committees: Small Business, Financial Services
View full profile →
Committee Sponsors
Ways and Means Committee
0 of 45 committee members cosponsored
No committee members have cosponsored this bill
Energy and Commerce Committee
0 of 54 committee members cosponsored
No committee members have cosponsored this bill
56 Republicans across these committees haven't cosponsored yet. Mobilize their constituents
H.R. 7837 Quick Facts
- Committee
- Ways and Means
- Chamber
- House
- Policy
- Health
- Introduced
- Mar 5, 2026
Referred to Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. for review
Mar 5, 2026
H.R. 7837 Common Questions
Which countries are used for most favored nation drug pricing under HR 7837?
Under the Most Favored Patient Act of 2026 (Section 2), the reference countries are Canada, Denmark, France, Germany, Italy, Japan, Switzerland, and the United Kingdom.
What is the most favored nation price for a drug under the Most Favored Patient Act?
Under the Most Favored Patient Act of 2026 (Section 2), the most-favored-nation price is the second-lowest applicable net price for the drug among the reference countries.
When would most favored nation drug pricing start under HR 7837?
According to H.R. 7837 Section 2, the CMMI Most Favored Nations Pricing Model must begin testing on January 1, 2029.
How long would the Most Favored Nations Pricing Model last under HR 7837?
Under the Most Favored Patient Act of 2026 (Section 2), the model would run for 5 years.
Can Medicaid patients get most favored nation drug prices under the Most Favored Patient Act?
Yes. Under the Most Favored Patient Act of 2026 (Section 2), people eligible for Medicaid Title XIX are most-favored-nation price eligible individuals for pharmacy or mail-order drugs.
Does HR 7837 apply to Medicare Part B and Part D drug coverage?
Yes. According to H.R. 7837 Section 2, eligible groups include Medicare Part D enrollees and Medicare Part B beneficiaries, including certain Medicare Advantage enrollees.
Which drugs are covered by the Most Favored Patient Act of 2026?
Under the Most Favored Patient Act of 2026 (Section 2), covered drugs include covered outpatient drugs, Medicare Part B payable drugs or biologics, and covered Part D drugs sold in 2 or more reference countries.
Can a drug manufacturer avoid the HR 7837 pricing requirements by signing an agreement?
Yes. Under the Most Favored Patient Act of 2026 (Section 2), a manufacturer with a covered agreement with the Secretary is not treated as a specified manufacturer subject to those requirements.
When do manufacturers have to sign a covered agreement under the Most Favored Patient Act?
According to H.R. 7837 Section 2, a covered agreement must be entered into by December 31, 2028.
Can HHS delay drug maker compliance with most favored nation pricing until April 2029?
Yes. Under the Most Favored Patient Act of 2026 (Section 2), the Secretary may suspend a specified manufacturer's requirements until April 1, 2029 if it is likely to enter a covered agreement before then.
Based on H.R. 7837 bill text
H.R. 7837 Bill Text
“To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model implementing most- favored-nation drug pricing. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE.”
Source: U.S. Government Publishing Office
Get notified when H.R. 7837 moves
Committee votes, floor action, cosponsor changes — straight to your inbox.
Bill alerts + Legisletter's monthly briefing. Unsubscribe anytime.
Health Bills
9 related bills we're tracking
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.
Oct 3, 2025
Mikaela Naylon Give Kids a Chance Act
Received in the Senate.
Dec 2, 2025
Improving Seniors’ Timely Access to Care Act of 2025
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 42 - 0.
Jul 15, 2026
CONNECT for Health Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 26, 2025
Momnibus Act
Referred to the Subcommittee on Health.
Apr 20, 2026
Right to Contraception Act
Referred to the House Committee on Energy and Commerce.
Feb 5, 2025
Women’s Health Protection Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 24, 2025
Medicare Patient Access and Practice Stabilization Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 31, 2025
ASAP Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 19, 2025
Trending Right Now
Bills gaining momentum across Congress
Great American Outdoors Act 250
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
Jun 24, 2026
Fit to Serve Act
Referred to the House Committee on Armed Services.
May 21, 2025
Humane Cosmetics Act of 2025
Referred to the House Committee on Energy and Commerce.
Feb 27, 2025
Tracking Health in Congress? Monitor bills, track cosponsor momentum, and launch advocacy campaigns — all from one advocacy platform.